Abstract:Wenxue Zhi, Xingzheng Zheng, Yulan Jin Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, 10006, People's Republic of China Correspondence: Yulan Jin, Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, 10006, People's Republic of China, Email We report on a 50-year-old postmenopausal woman who presented with abnormal uterine bleeding and pelvic pain due to a uterine solid mass grew from the uterine fundus to the cervix and with so far undescribed obviously gelatinous grossly change, which was suspected of myxoid leiomyosarcoma in intraoperative diagnosis. Morphologically, the tumor cells displayed haphazard fascicles of uniform mild-to-moderate heteromorphic spindle cell component with significant and abundant myxoid stroma, forming signet ring cells and microcysts. Immunohistochemically, the tumour cells were diffusely positivefor CD10 and cyclin D1 and negative for Desmin and SMA, but the expression of BCOR staining was not present. The FISH study showed a positive BCOR gene break probe, and the RNA sequencing revealed an identified reciprocal fusion gene ZC3H7B-BCOR. The case was finally diagnosed as ZC3H7B-BCOR high-grade endometrial stromal sarcoma. Tumor recurrence occurred rapidly on the pelvic peritoneal and vaginal 2 months after resection. In conclusion, these findings further support ZC3H7B-BCOR HGESS has a poor prognosis and molecular testing of uterine mesenchymal tumors with myxoid matrix and unusual grossly presentation is recommended to avoid misdiagnosis. Keywords: ZC3H7B-BCOR, endometrial stromal sarcoma, postmenopausal woman Endometrial stromal and related tumors are a rare and complex subset of mesenchymal uterine neoplasms. In the past decade, the classification of this rare group of tumors has changed significantly with the discovery of recurrent and mutually exclusive genomic alterations as next-generation sequencing analysis has been increasingly applied in clinical and research applications. Endometrial stromal and related tumours have been divided into four categories in the most recent classification by the World Health Organization (WHO, 2020): endometrial stromal nodule (NST), low-grade endometrial stromal sarcoma (LGESS), high-grade endometrial stromal sarcoma (HGESS) and undifferentiated uterine sarcoma (UUS), 1 and this distinction is predominantly guided by underlying genetic alterations. The most common HGESS are YWHAE-NUTM2 fusions HGESS containing t(10;17) (q22;p13), which consist of small, high-grade round cells arranged in lamellar and nested heterotypes with active mitotic figures. Recently, another newly identified group of ESS with a ZC3H7B-BCOR gene fusion was considered as a separate group of HGESS in addition to the known YWHAE-NUTM2 fusion, showing high malignant potential with more aggressive clinical behavior and different histological characteristics and immunohistochemical (IHC) expression. 2 However, due to its rarity, the clinicopathological features remain to be elucidated and awareness of this tumor should also be enhanced. Here, we report one case of ZC3H7B-BCOR fused HGESS with classic morphological characteristics and uncommon grossly finding. A 50-year-old postmenopausal woman with abnormal uterine bleeding and pelvic pain, lasting one month. CT scan showed a large uterine mass, measuring 13.6 cm × 10.3 cm × 10 cm, with a high possibility of endometrial lesions and possible invasion of myometrium and upper cervix. Then, the patient underwent exploratory laparotomy. Intraoperative findings were that the diameter of the posterior uterine wall mass was about 10 cm, with a gray-yellow cut surface. The mass infiltrates beyond the uterine serosal membrane. Scattered mass lesions can be seen on the surface of omentum, mesoappendix and mesentery of the small intestine. The patient had undergone a total abdominal hysterectomy with bilateral salpingo-oophorectomy and performed an intraoperative diagnosis. Grossly, the uterine solid mass grew from the uterine fundus to the cervix and up to 16 cm in size. It is located in the deep myometrium and partly penetrated the serosa with a tan-yellow and obviously gelatinous cut surface (Figure 1A). Frozen sections showed that the tumour was composed of fascicular spindle cells and had a destructive invasive pattern of the myometrium, which is associated with abundant myxoid stroma (Figure 1B). The cells have scant to moderate eosinophilic cytoplasm and mild-moderate nuclear atypia. Mitotic figures can easily be found in some areas in the section (Figure 1C), but necrosis was not seen. The intraoperative diagnosis was that it is a malignant mesenchymal tumour of the uterus with suspicious -Abstract Truncated-

Epithelioid Leiomyosarcoma of Broad Ligament Harboring PGR-NR4A3 and UBR5-PGR Gene Fusions: a Unique Case Report.

A Novel Molecular Cytogenetic Finding of Leiomyomatosis Peritonealis Disseminata.

Expanding the spectrum of GLI1-altered mesenchymal tumors-A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract

Uterine Tumours with Myogenic Differentiation Harbouring SRF::RELA Fusions.

PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms

A Rare Pulmonary Myoepithelial Tumor with Novel TRPS1-PLAG1 Fusions

ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity

["Benign metastasizing leiomyoma"? A case report without evidence for unbalanced cytogenetic aberrations]

Case Report: the First Report of PPP2R1A Mutations in Mesonephric-Like Adenocarcinoma of Endometrial Carcinoma

Rare Recurrent EWSR1-PLAGL1 Rearranged Intracranial Tumor With Biphasic Epithelioid Differentiation: One Case Report With Literature Review

Malignant Peripheral Nerve Sheath Tumor (MPNST) With Smooth Muscle Differentiation of the Uterus—A Case Report With Emphasis on Diagnostic Pitfalls and Value of DNA Methylation Analysis

Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma

Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype

Several Fusion Genes Identified in a Spermatic Cord Leiomyoma With Rearrangements of Chromosome Arms 3p and 21q

A rare case of aggressive uterine leiomyosarcoma: a case report

A Rare Case of Pleural Epithelioid Mesothelioma With a Prominent Myxoid Stroma Reported With Morphology, Fluorescent In Situ Hybridization, and Ultrastructural Findings

ZC3H7B-BCOR High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report and Literature Review

Case report: High grade serous fallopian tube carcinoma with rare NRG1 gene fusion presenting as widespread peritoneal carcinomatosis

Primary mediastinal seminoma with leiomyosarcoma: a rare case report

Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma